(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

LUNG BIOENGINEERING

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: US

Quick snapshot

LUNG BIOENGINEERING

ST13

US500000086844642

Class

42, 44

Filing

86844642

Registration

5313840

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

Attention: there is active risk

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

29

Latest update

01/02/2024

Classification

Registered

Trademark type

Word

Nice classes

42, 44

Filing date

12/10/2015

Registration date

10/17/2017

Expiration date

-

Recommended action

Perform a full collision analysis and validate classes before any filing or trademark investment.

Next step

These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.

Complete case details

Structured fields from the responsible authority and the official record.

Status date

01/02/2024

Last transaction

01/02/2024

Responsible office

United States Patent and Trademark Office

Status code

701

Official register

Supplemental Register

Filing basis

Intent to use

First use anywhere

11/30/2015

First use in commerce

11/30/2015

Drawing code

4

Owner type

03

Owner location

Silver Spring, MD, US

Examiner

KON, ELISSA GARBER

Law office

L60

Current location

TMEG LAW OFFICE 106

Holders and representatives

Holders

Lung Bioengineering Inc.

Representatives

Norm J. Rich FOLEY & LARDNER LLP

Technical classification

Nice Classes

Class 42Class 44

Vienna Codes

No Vienna codes available.

Goods and services

Class 42

Medical and scientific research in the field of preservationmodificationengineering of human organsincluding lungs

Class 44

Health care servicesservices to perfuse human organs such as lungsliversheartskidneys after recovery from an organ donor and before transplantation into a recipient

Publications

History of USPTO decisions and trademark events.

29 publications found

NAS8

NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED

01/02/2024

8.OK

REGISTERED - SEC. 8 (6-YR) ACCEPTED

01/02/2024

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

01/02/2024

ES8R

TEAS SECTION 8 RECEIVED

10/13/2023

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

10/17/2022

R.SR

REGISTERED-SUPPLEMENTAL REGISTER

10/17/2017

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

09/14/2017

ALIE

ASSIGNED TO LIE

09/01/2017

CNTA

APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER

08/18/2017

AAUA

NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED

03/30/2017

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

03/29/2017

IUAA

USE AMENDMENT ACCEPTED

03/29/2017

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

03/28/2017

ERFR

TEAS REQUEST FOR RECONSIDERATION RECEIVED

03/28/2017

AUPC

AMENDMENT TO USE PROCESSING COMPLETE

03/28/2017

IUAF

USE AMENDMENT FILED

03/28/2017

EAAU

TEAS AMENDMENT OF USE RECEIVED

03/27/2017

GNFN

NOTIFICATION OF FINAL REFUSAL EMAILED

09/30/2016

GNFR

FINAL REFUSAL E-MAILED

09/30/2016

CNFR

FINAL REFUSAL WRITTEN

09/30/2016

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

09/19/2016

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

09/19/2016

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

09/19/2016

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

03/29/2016

GNRT

NON-FINAL ACTION E-MAILED

03/29/2016

CNRT

NON-FINAL ACTION WRITTEN

03/29/2016

DOCK

ASSIGNED TO EXAMINER

03/28/2016

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

12/14/2015

NWAP

NEW APPLICATION ENTERED

12/14/2015

Continuous trademark protection

Get notified about every new filing that threatens LUNG BIOENGINEERING or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.